147 related articles for article (PubMed ID: 23721635)
21. Genetics of melanoma predisposition.
Lin J; Hocker TL; Singh M; Tsao H
Br J Dermatol; 2008 Aug; 159(2):286-91. PubMed ID: 18547303
[TBL] [Abstract][Full Text] [Related]
22. Microphthalmia transcription factor: a specific marker for malignant melanoma.
Vachtenheim J; Borovanský J
Prague Med Rep; 2004; 105(3):318-24. PubMed ID: 15782558
[TBL] [Abstract][Full Text] [Related]
23. Progress report on the major clinical advances in patient-oriented research into familial melanoma (2013-2018).
Visser M; van der Stoep N; Gruis N
Fam Cancer; 2019 Apr; 18(2):267-271. PubMed ID: 30659395
[No Abstract] [Full Text] [Related]
24. Differential diagnosis of melanocytic lesions and molecular biology.
Dummer R; Kerl K; Mihic D; Kamarachev J
Arch Dermatol; 2011 Feb; 147(2):232-3. PubMed ID: 21339451
[No Abstract] [Full Text] [Related]
25. Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists.
Emanuel PO; Andea AA; Vidal CI; Missall TA; Novoa RA; Bohlke AK; Hughes SR; Hurley MY; Kim J
J Cutan Pathol; 2018 Nov; 45(11):839-846. PubMed ID: 30039879
[TBL] [Abstract][Full Text] [Related]
26. An Update Regarding the Molecular Genetics of Melanocytic Neoplasms and the Current Applications of Molecular Genetic Technologies in Their Diagnosis and Treatment.
Kiavash K; Bluth MH; Thompson AD
Clin Lab Med; 2018 Jun; 38(2):385-399. PubMed ID: 29776637
[TBL] [Abstract][Full Text] [Related]
27. Array-based comparative genomic hybridization analysis of a pleomorphic myxoid liposarcoma.
Creytens D; van Gorp J; Ferdinande L; Van Roy N; Libbrecht L
J Clin Pathol; 2014 Sep; 67(9):834-5. PubMed ID: 24970901
[No Abstract] [Full Text] [Related]
28. Modest association of malignant melanoma with the rs910873 and rs1885120 markers on chromosome 20: a population-based study.
Debniak T; Gapska P; Serrano-Fernandez P; Rassoud I; Cybulski C; Maleszka R; Sulikowski M; Narod S; Lubiński J
Melanoma Res; 2010 Apr; 20(2):159-60. PubMed ID: 20224305
[No Abstract] [Full Text] [Related]
29. Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma.
Held L; Eigentler TK; Metzler G; Leiter U; Messina JL; Glass LF; Garbe C; Bauer J
Am J Pathol; 2013 Mar; 182(3):640-5. PubMed ID: 23261261
[TBL] [Abstract][Full Text] [Related]
30. Main clues in the pathologic diagnosis of melanoma: is molecular genetics helping?
Ferrara G; Senetta R; Paglierani M; Massi D
Dermatol Ther; 2012; 25(5):423-31. PubMed ID: 23046021
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic techniques for primary cutaneous melanoma.
Lien MH; Sondak VK
G Ital Dermatol Venereol; 2009 Apr; 144(2):187-94. PubMed ID: 19357625
[TBL] [Abstract][Full Text] [Related]
32. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
Bauer J; Bastian BC
Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathology of malignant melanoma: changing the clinical practice paradigm toward a personalized approach.
Bradish JR; Cheng L
Hum Pathol; 2014 Jul; 45(7):1315-26. PubMed ID: 24856851
[TBL] [Abstract][Full Text] [Related]
34. [Molecular testing in malignant melanoma].
Dundr P; Staněk L; Němejcová K; Jakša R
Cesk Patol; 2014 Jul; 50(3):127-31. PubMed ID: 25186593
[TBL] [Abstract][Full Text] [Related]
35. A proposal for improving multicolor FISH sensitivity in the diagnosis of malignant melanoma using new combined criteria.
Kerl K; Palmedo G; Wiesner T; Mentzel T; Rütten A; Schärer L; Paredes B; Hantschke M; Kutzner H
Am J Dermatopathol; 2012 Aug; 34(6):580-5. PubMed ID: 22668575
[TBL] [Abstract][Full Text] [Related]
36. Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis.
Miedema J; Andea AA
Mod Pathol; 2020 Jul; 33(7):1318-1330. PubMed ID: 32066861
[TBL] [Abstract][Full Text] [Related]
37. Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA): Its usefulness as an adjunctive diagnostic tool for melanocytic tumors.
Takata M; Suzuki T; Ansai S; Kimura T; Shirasaki F; Hatta N; Saida T
J Dermatol Sci; 2005 Oct; 40(1):51-7. PubMed ID: 16054806
[TBL] [Abstract][Full Text] [Related]
38. [Molecular diagnostics in melanoma].
Lang R; Bauer JW; Laimer M
Hautarzt; 2015 Apr; 66(4):277-81. PubMed ID: 25783213
[TBL] [Abstract][Full Text] [Related]
39. [Molecular and immunohistochemical diagnostics in melanoma].
Schilling B; Griewank KG
Hautarzt; 2016 Jul; 67(7):511-8. PubMed ID: 27270408
[TBL] [Abstract][Full Text] [Related]
40. What's new in prognostication of melanoma in the dermatopathology laboratory?
Bangash HK; Romegialli A; Dadras SS
Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
